|
US2694711A
(en)
|
1952-12-02 |
1954-11-16 |
American Cyanamid Co |
Quinazolone antimalarial compounds
|
|
US6008217A
(en)
*
|
1995-12-20 |
1999-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
|
US6204261B1
(en)
*
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
|
DE19642451A1
(de)
|
1996-10-15 |
1998-04-16 |
Merck Patent Gmbh |
Aminothiophencarbonsäureamide
|
|
EP1614676A4
(en)
|
2003-03-27 |
2009-03-25 |
Kirin Pharma Kk |
CONNECTION TO INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICAMENT CONTAINING THEREOF
|
|
EP1781647A2
(en)
|
2004-07-22 |
2007-05-09 |
Astex Therapeutics Limited |
Thiazole and isothiazole derivatives as protein kinase inhibitors
|
|
US20070010537A1
(en)
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
JP2008543968A
(ja)
|
2005-06-28 |
2008-12-04 |
オーキッド リサーチ ラボラトリーズ リミテッド |
新規なピラゾロピリミジノン誘導体
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
CN101287728A
(zh)
|
2005-08-17 |
2008-10-15 |
先灵公司 |
新的高亲和力噻吩基和呋喃基激酶配体
|
|
ME02420B
(me)
|
2006-09-26 |
2016-09-20 |
Celgene Corp |
5-supstituirani derivati kinazolinona kao sredstva protiv raka
|
|
US20080255161A1
(en)
|
2007-04-11 |
2008-10-16 |
Dmitry Koltun |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
|
US8703768B2
(en)
|
2010-06-09 |
2014-04-22 |
Hoffmann-La Roche Inc. |
Nitrogen containing heteroaryl compounds
|
|
US20120165330A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Sirtris Pharmaceuticals, Inc. |
Quinazolinone and related analogs as sirtuin modulators
|
|
CN103288771B
(zh)
|
2012-02-29 |
2014-12-03 |
中国中化股份有限公司 |
异噻唑类化合物及其作为杀菌剂的用途
|
|
US9452973B2
(en)
|
2012-05-04 |
2016-09-27 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
JP6359563B2
(ja)
|
2013-01-14 |
2018-07-18 |
デュートルクス・リミテッド・ライアビリティ・カンパニーＤｅｕｔｅＲｘ， ＬＬＣ |
３−（５置換−４−オキソキナゾリン−３（４ｈ）−イル）−３−ジュウテロピペリジン−２，６−ジオン誘導体
|
|
CN105524053B
(zh)
|
2014-10-19 |
2020-06-05 |
广东东阳光药业有限公司 |
四氢苯并噻吩化合物
|
|
US11608340B2
(en)
|
2014-11-17 |
2023-03-21 |
Rhode Island Hospital |
Nanomaterial compositions, synthesis, and assembly
|
|
ES2969565T3
(es)
|
2015-09-30 |
2024-12-13 |
Max Planck Ges Zur Foerderung Derwissenschaften E V |
Derivados heteroarílicos como inhibidores de la sepiapterina reductasa
|
|
KR102331013B1
(ko)
|
2016-01-14 |
2021-11-26 |
강푸 바이오파마슈티칼즈 리미티드 |
퀴나졸리논 유도체, 이의 제조방법, 약학 조성물 및 적용
|
|
KR101870968B1
(ko)
|
2016-02-02 |
2018-06-25 |
부산대학교 산학협력단 |
Ppar, fxr 및 ampk 활성화 효능을 갖는 신규 티오펜 화합물 또는 이의 약제학적으로 허용 가능한 염 및 이의 의학적 용도
|
|
US10934280B2
(en)
|
2016-08-15 |
2021-03-02 |
Eli Lilly And Company |
Condensed thiophene derivatives useful as NaPi-IIb inhibitors
|
|
US11000491B2
(en)
|
2017-05-05 |
2021-05-11 |
Hepanova, Inc. |
Amino-aryl-benzamide compounds and methods of use thereof
|
|
CA3087830A1
(en)
|
2018-02-08 |
2019-08-15 |
Enyo Pharma |
Non-fused thiophene derivatives and their uses
|
|
US20210000906A1
(en)
|
2018-03-21 |
2021-01-07 |
Ionis Pharmaceuticals, Inc. |
Modulation of hsd17b13 expression
|
|
CN112805005A
(zh)
*
|
2018-08-24 |
2021-05-14 |
拓臻股份有限公司 |
甲状腺素受体β促效剂化合物
|
|
US11957687B2
(en)
*
|
2019-07-02 |
2024-04-16 |
Regeneron Pharmaceuticals, Inc. |
Modulators of HSD17B13 and methods of use thereof
|
|
WO2021211974A1
(en)
*
|
2020-04-18 |
2021-10-21 |
Inipharm, Inc. |
Hsd17b13 inhibitors and uses thereof
|
|
KR20230066554A
(ko)
*
|
2020-07-24 |
2023-05-16 |
이니팜, 인크. |
퀴나졸리논 hsd17b13 억제제 및 이의 용도
|
|
EP4185381A4
(en)
|
2020-07-24 |
2024-08-21 |
Inipharm, Inc. |
Thiophene hsd17b13 inhibitors and uses thereof
|
|
CN116056695A
(zh)
|
2020-08-05 |
2023-05-02 |
埃尼奥制药公司 |
治疗慢性肾病的方法
|
|
WO2022040324A1
(en)
*
|
2020-08-18 |
2022-02-24 |
Metrea Biosciences, Inc. |
COMPOUNDS AND METHODS OF MODULATING 17β-ΗYDROXYSTEROID DEHYDROGENASE TYPE 13
|
|
MX2023003677A
(es)
*
|
2020-09-30 |
2023-06-22 |
Fl2022 001 Inc |
Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
|
|
EP4221703A1
(en)
*
|
2020-09-30 |
2023-08-09 |
FL2022-001, Inc. |
Hsd17b13 inhibitors and uses thereof
|
|
EP4221701A1
(en)
*
|
2020-09-30 |
2023-08-09 |
FL2022-001, Inc. |
Hsd17b13 inhibitors and uses thereof
|
|
US20230416802A1
(en)
|
2020-11-06 |
2023-12-28 |
Inipharm, Inc. |
Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatment
|
|
AU2021377248B2
(en)
|
2020-11-13 |
2025-12-18 |
Inipharm, Inc. |
Dichlorophenol hsd17b13 inhibitors and uses thereof
|
|
WO2022216626A1
(en)
|
2021-04-05 |
2022-10-13 |
Inipharm, Inc. |
Hydroxypyridine hsd17b13 inhibitors and uses thereof
|
|
EP4319872A4
(en)
|
2021-04-05 |
2025-03-12 |
Inipharm, Inc. |
Thiazole/isothiazole hsd17b13 inhibitors and uses thereof
|
|
CN118103038A
(zh)
*
|
2021-08-20 |
2024-05-28 |
英安塔制药有限公司 |
17β-羟基类固醇脱氢酶13型抑制剂及其使用方法
|
|
IL314415A
(en)
|
2022-01-26 |
2024-09-01 |
Inipharm Inc |
Thiazole 2-converted HSD17B13 inhibitors and uses thereof
|
|
JP2025523357A
(ja)
|
2022-06-09 |
2025-07-23 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｈｓｄ１７ｂ１３阻害剤
|